Martin Edwards
CIK 1640073 · last filed 2025-10-08
Martin Edwards is a corporate insider who has filed 32 SEC Form 4 insider transactions across 5 companies since 2019. The most recent filing, for VRNA, was dated Oct 8, 2025. Across all open-market trades the lifetime net is −$55.0K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
5
32
-$55.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Verona Pharma plc (VRNA) Delisted | Director | 72,000 | $106.91 | $7.70M | -$103.8K | 10 | 2025-10-08 |
| Inozyme Pharma, Inc. (INZY) Delisted | Director | — | $4.00 | — | $0 | 5 | 2024-06-20 |
| Morphic Holding, Inc. (MORF) Delisted | Director | 2,376 | $56.99 | $135.4K | $48.8K | 7 | 2024-06-05 |
| REATA PHARMACEUTICALS INC (RETA) Delisted | Director | 0 | $172.36 | $0 | $0 | 6 | 2023-09-26 |
| KALV | Director | — | $27.00 | — | $0 | 3 | 2021-10-04 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-08 | Verona Pharma plc (VRNA) Delisted | Mixed | −157,992 | $0 | EDGAR |
| 2025-08-05 | Verona Pharma plc (VRNA) Delisted | Mixed | +13,192 | -$142.1K | EDGAR |
| 2025-04-29 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-08-21 | — | Disp (D) | −2,376 | $0 | |
| 2024-06-20 | Inozyme Pharma, Inc. (INZY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-05 | Morphic Holding, Inc. (MORF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-04-30 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-11-22 | Verona Pharma plc (VRNA) Delisted | Buy (P) | +33,736 | $62.0K | EDGAR |
| 2023-11-15 | Morphic Holding, Inc. (MORF) Delisted | Buy (P) | +2,376 | $48.8K | EDGAR |
| 2023-09-26 | REATA PHARMACEUTICALS INC (RETA) Delisted | Disp (D) | −6,116 | $0 | EDGAR |